JRSIS Health Care Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 0.043317 million. Net loss was USD 0.105005 million compared to USD 36.18 million a year ago. Basic loss per share from continuing operations was USD 0.018 compared to USD 0.029 a year ago. Diluted loss per share from continuing operations was USD 0.018 compared to USD 0.029 a year ago. Basic loss per share was USD 0.018 compared to USD 8.247 a year ago. Diluted loss per share was USD 0.018 compared to USD 8.247 a year ago.
For the six months, revenue was USD 0.043317 million. Net loss was USD 0.224169 million compared to USD 33.54 million a year ago. Basic loss per share from continuing operations was USD 0.038 compared to USD 0.048 a year ago. Diluted loss per share from continuing operations was USD 0.038 compared to USD 0.048 a year ago. Basic loss per share was USD 0.038 compared to USD 10.734 a year ago. Diluted loss per share was USD 0.038 compared to USD 10.734 a year ago.